The RWJF-funded Placebo Seminar Series continued on February 11, 2014 with an address by Tanya Luhrmann, Watkins University Professor in the Stanford Anthropology Department. Discussants were: Arthur Kleinman (Anthropology, Psychiatry), Anne Harrington (History of Science), and Ted Kaptchuk (Medicine). View the lecture and discussion in full here.
You can also join the conversation online by following the Twitter hashtag #placebotalks.
• Michael J. Barry, MD, President, Informed Medical Decisions Foundation
• Josephine P. Briggs, MD, Director, NCCAM, National Institutes of Health
• Joann G. Elmore, MD, MPH, Professor of Medicine, University of Washington
• Russell S. Phillips, MD, Director, HMS Center for Primary Care
• Harold C. Sox, MD, Associate Director, Dartmouth Institute for Health Policy & Clinical Practice
“The placebo effect is people getting better without any active ingredients.” Harvard Medical School’s Ted Kaptchuk, a Robert Wood Johnson Foundation grantee, cuts across clinical specialties through robust research and specialized technologies, to understand and institutionalize one of the most exciting, and controversial ideas in modern medicine.
Based on extensive interviews with Ted Kaptchuk and a number of his colleagues and associates, this article sums up the ground-breaking work that Prof. Kaptchuk has overseen. Read the full text of the article here.
PiPS has been awarded $250,000 by the Robert Wood Johnson Foundation. The funds will be used to create a high-impactseminar series that examines the potential of placebo studies to contribute to the transformation of health care. Over a period of approximately 18 months starting in June, 2013, a series of symposia will be held that bring together representatives from relevant disciplines including clinical specialties, neuroscience, health policy, anthropology,sociology, bioethics, and the history of medicine. The symposia will be structured to encourage an in-depth conversation that broadens the discourse about how the phenomenon known as placebo response can be utilized to enhance the provider-patient relationship, improve patient outcomes, reduce morbidity, and help control health care costs. Incentives will be offered that encourage participants to engage in collaborations. Certain events will be open to the public as well as the medical community. Register as a member to learn more about these andother events. Or call617-945-7827 for more information.
A patient’s genetic makeup may explain the “placebo effect,” in which people perceive that a fake treatment makes them feel better, according to a study by PiPS researchers. The findings may help researchers design better clinical trials.
Radio Boston (local NPR station) interviews PiPS Director, Ted Kaptchuk, and Arthur Barsky, Director of Psychiatric Research at Brigham and Women’s Hopsital and professor at Harvard Medical School, on ethical and other questions relating to the nocebo effect.
In February 2012, PiPS Director Ted Kaptchuk and PiPS Senior Faculty Arthur Barsky presented at Talks@Twelve, a quarterly lecture given to the Harvard Medical School community. We just received the a link to the video filmed by the Harvard Medical School Communications Office. To watch, click here.